366 endorsements reference manual V 37



Yüklə 172,19 Kb.
Pdf görüntüsü
səhifə2/3
tarix19.03.2017
ölçüsü172,19 Kb.
#12058
1   2   3

Surgical therapy

Surgical access to facilitate mechanical instrumentation of the 

roots has been utilized to treat chronic periodontitis for dec- 

ades. A surgical approach to the treatment of periodontitis is 

utilized in an attempt to: 1) provide better access for removal 

of etiologic factors; 2) reduce deep probing depths; and 3) re- 

generate or reconstruct lost periodontal tissues.

96-98


 

Clinical trials indicate that both surgical and nonsurgical 

approaches can be effective in achieving stability of clinical 

attachment levels.

60-65,99-103

 Flap reflection is capable, however, 

of increasing the efficacy of root debridement, especially at 

sites with deep probing depths or furcations.

60-65,70,72,99-104

 

Nevertheless, complete calculus removal, even with surgi-



cal access, may not always be achieved.

70,72,104

 The addition of 

osseous resection during surgical procedures appears to produce 

greater reduction of probing depth due to gingival reces-

sion,


62,64,65

 particularly in furcations.

66

 Regardless of the type of 



therapy, furcated teeth are problematic since they are still more 

likely to lose clinical attachment than nonfurcated teeth.

66,67,105

  

While these overall findings are helpful, the practitioner 



 

should base specific decisions for therapy on findings for each 

individual patient.

Regenerative surgical therapy

The optimal goal of therapy for individuals who have lost a 

significant amount of periodontal attachment is regeneration 

of lost tissues. While root debridement in combination with 

plaque control has demonstrated efficacy in resolving inflam-

mation and arresting periodontitis,

26,27,60-65

 healing typically 

results in the formation of a long junctional epithelium

106-108


 

with remodeling of the alveolus.

109

 Similarly, surgical debride-



ment alone does not induce significant amounts of new 

 

connective tissue attachment.



110,111

 However, some bone fill 

may occur in selected sites.

107,112


  Clinical trials suggest that obtaining new periodontal 

attachment or regenerating lost tissues is enhanced by the 

use of adjunctive surgical technique devices and materials. 

Chemical agents that modify the root surface, while promoting 

new attachment, have shown variable results when used in 

humans.


113-118

 Bone grafting

119-125

 and guided tissue regeneration 



(GTR) techniques, with or without bone replacement grafts,

126-133 


may be successful when used at selected sites with advanced 

attachment loss. The use of biologically engineered tissue induc-

tive proteins (eg, growth factors, extracellular matrix proteins, 

and bone morphogenic proteins) to stimulate periodontal or 

osseous regeneration has also shown promise.

134-142


 Literature  

reviews on periodontal regeneration

143,144

 and mucogingival 



therapy

145


 provide additional information regarding these 

 

therapies.



 

Regenerative therapy and other treatment modalities can 

be affected by several risk factors (eg, diabetes and tobacco 

use) which can diminish periodontal treatment outcomes.

146

 In 


this regard, cigarette smoking is associated with a high risk for 

progressive periodontitis

9-13,147

 and treatment for periodontitis 

may be less effective in smokers than non-smokers.

148-150


 These 

factors are reviewed in more depth in the Academy’s position 

paper Tobacco Use and the Periodontal Patient.

151


 To maximize 

effective prevention and treatment of periodontitis, patients 

should be encouraged to stop smoking and to stop using  

smokeless tobacco.

Occlusal management

Several studies indicated that excessive occlusal forces do not 

initiate plaque-induced periodontal disease or connective tissue 

attachment loss (periodontitis).

152-155

 However, other investiga-



tions suggest that tooth mobility may be associated with adverse 

effects on the periodontium and affect the response to therapy 

with respect to gaining clinical attachment.

156,157


 With regards to 

treatment, occlusal therapy may aid in reducing tooth mobility 

and gaining some bone lost due to traumatic occlusal forces.

158


 

Occlusal equilibration also may be used to ameliorate a variety 

of clinical problems related to occlusal instability and restorative 

needs.


159

 Clinicians should use their judgment as to whether 

or not to perform an occlusal adjustment as a component of 

periodontal therapy based upon an evaluation of clinical fac- 

tors related to patient comfort, health and function.

160


370    ENDORSEMENTS 

REFERENCE MANUAL     V 37 

/

 NO 6     15 



/

 16


Periodontal maintenance procedures

Periodic monitoring of periodontal status and appropriate 

maintenance procedures should be part of the long-term 

 

treatment plan for managing chronic periodontitis.



28

 Although 

experimental studies have demonstrated very successful treat-

ment outcomes when patients are professionally maintained  

at two-week intervals,

161 


such a program is impractical for  

most chronic periodontitis patients. Therefore, to maximize suc- 

cessful therapeutic outcomes, patients must maintain effective 

daily plaque control. It also appears that in-office periodontal  

maintenance at three to four month intervals can be effective  

in maintaining most patients.

4

 A more comprehensive review  



on this subject can be found in the American Academy of  

Periodontology’s position paper entitled Supportive Periodontal 



Therapy (SPT).

162


Summary

The inflammatory components of plaque induced gingivitis 

and chronic periodontitis can be managed effectively for the 

majority of patients with a plaque control program and non- 

surgical and/or surgical root debridement coupled with con- 

tinued periodontal maintenance procedures. Some patients  

may need additional therapeutic procedures. All of the 

 

therapeutic modalities reviewed in this position paper may be  



utilized by the clinician at various times over the long-term  

management of the patient’s periodontal condition.

References 

 

1.  American Academy of Periodontology. The pathogen-



esis of periodontal diseases (position paper). J Periodontol 

1999;70:457-70.

  2.  American Academy of Periodontology. Diagnosis of 

Periodontal Diseases (position paper). Chicago, Ill: The 

American Academy of Periodontology; April 1995.

  3.  Armitage GC. Development of a classification system 

for periodontal diseases and conditions. Ann Periodontol 

1999;4:1-6.

  4.  Ramfjord SP. Maintenance care and supportive perio- 

dontal therapy. Quintessence Int 1993;24:465-71.

  5.  Page RC. Gingivitis. J Clin Periodontol 1986;13:345-59.

  6.  Ranney RR, Debski BF, Tew JG. Pathogenesis of gingi- 

vitis and periodontal disease in children and young  

adults. Pediatr Dent 1981;3:89-100.

  7.  Socransky SS, Haffajee AD. Microbial mechanisms in the 

pathogenesis of destructive periodontal diseases: A critical 

assessment. J Periodont Res 1991;26:195-212.

  8.  Wolff L, Dahlen G, Aeppli D. Bacteria as risk markers  

for periodontitis. J Periodontol 1994;65:498-510.

  9.  Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk  

for periodontal disease. I. Risk indicators for attachment 

loss. J Periodontol 1994;65:260-7.

 10.  Grossi SG, Genco RJ, Machtei EE, et al. Assessment of 

risk for periodontal disease. II. Risk indicators for alveolar  

bone loss. J Periodontol 1995;66:23-9.

 11.  Ismail A, Morrison E, Burt B, Caffesse R, Kavanaugh  MT. 

Natural history of periodontal disease in adults: Findings  

from the Tecumseh Periodontal Disease Study, 1959- 

1987. J Dent Res 1990;69:430-5.

 12.  Haber J, Wattles J, Crowley M, Mandell R, Joshipurak K, 

Kent RL. Evidence for cigarette smoking as a major risk 

factor for periodontitis. J Periodontol 1993;64:16-23.

 13.  Bergstrom J, Preber H. Tobacco use as a risk factor. J 

Periodontol 1994;65:545-50.

 14.  Oliver RC, Tervonen T. Diabetes: A risk factor for perio-

dontitis in adults? J Periodontol 1994;65:530-8.

 15.  Michalowicz BS. Genetic and heritable risk factors in 

periodontal disease. J Periodontol 1994;65:479-88.

 16.  Löe H, Theilade E, Jensen SB. Experimental gingivitis in 

man. J Periodontol 1965;36:177-87.

 17.  Theilade E, Wright WH, Jensen SB, Löe H. Experimental 

gingivitis in man. II. A longitudinal clinical and bacterio-

logical investigation. J Periodont Res 1966;1:1-13.

 18.  Lindhe J, Axelsson P. The effect of a preventive program- 

me on dental plaque, gingivitis, and caries in school chil- 

dren. Results after one and two years. J Clin Periodontol  

1974;1:126-38.

 19.  Suomi JD, Greene JC, Vermillion JR, Doyle J, Chang JJ, 

Leatherwood EC. The effect of controlled oral hygiene 

procedures on the progression of periodontal disease in 

adults: Results after third and final year. J Periodontol  

1971;42:152-60.

 20.  Axelsson P, Lindhe J. Effect of controlled oral hygiene 

procedures on caries and periodontal disease in adults. 

Results after 6 years. J Clin Periodontol 1981;8:239-48.

 21.  De la Rosa M, Guerra JZ, Johnston DA, Radike AW.  

Plaque growth and removal with daily toothbrushing. J  

Periodontol 1979;50:661-4.

 22.  MacGregor IDM, Rugg-Gunn AJ, Gordon PH. Plaque 

levels in relation to the number of toothbrushing strokes 

in uninstructed English schoolchildren. J Periodont Res 

1986;21:577-82.

 23.  Lang NP, Cumming BR, Löe H. Toothbrushing fre- 

quency as it relates to plaque development and gingival 

health. J Periodontol 1973;44:396-405.

 24.  Listgarten MA, Schifter CC, Laster L. 3-year longitudinal 

study of the periodontal status of an adult population  

with gingivitis. J Clin Periodontol 1985;12:225-38.

 25.  Agerbaek N, Melsen B, Lind OP, Glavind L, Kristiansen 

B. Effect of regular small group instruction per se on  

oral health status of Danish schoolchildren. Community 

Dent Oral Epidemiol 1979;7:17-20.

 26.  Tagge DL, O’Leary TJ, El-Kafrawy AH. The clinical 

and histological response of periodontal pockets to root  

planing and oral hygiene. J Periodontol 1975;46:527-33.

 27.  Lövdal A, Arno A, Schei O, Waerhaug J. Combined effect 

of subgingival scaling and controlled oral hygiene on  

the incidence of gingivitis. Acta Odontol Scand 1961;19: 

537-55.

 28.  Hancock EB. Prevention. Ann Periodontol 1996;1:223-49.



             AMERICAN ACADEMY OF PEDIATRIC DENTISTRY

    ENDORSEMENTS    371

 29.  Mandel ID. Antimicrobial mouthrinses: Overview and 

update. J Am Dent Assoc 1994;125(suppl 2):2S-10S.

 30.  Brecx M, Brownstone E, MacDonald L, Gelskey S, Cheang 

M. Efficacy of Listerine, Meridol, and chlorhexidine as 

supplements to regular tooth-cleaning measures. J Clin 

Periodontol 1992;19:202-7.

 31.  Pitcher GR, Newman HN, Strahan JD. Access to subgingival 

plaque by disclosing agents using mouthrinsing and direct 

irrigation. J Clin Periodontol 1980;7:300-8.

 32.  American Academy of Periodontology. The role of supra- 

and subgingival irrigation in the treatment of periodontal  

diseases (position paper). Chicago, Ill: The American 

Academy of Periodontology; April 1995.

 33.  Mealey BL. Periodontal implications: Medically compro-

mised patients. Ann Periodontol 1996;1:293-303.

 34.  Drinkard CR, Decher L, Little JW, et al. Periodontal status 

of individuals in early stages of human immunodeficiency  

virus infection. Community Dent Oral Epidemiol 1991; 

19:281-5.

 35.  Friedman RB, Gunsolley J, Gentry A, Dinius A, Kaplowitz 

L, Settle J. Periodontal status of HIV seropositive and  

AIDS patients. J Periodontol 1991;62:623-7.

 36.  Riley C, London JP, Burmeister JA. Periodontal health in  

200 HIV-positive patients. J Oral Pathol Med 1992;21: 

124-7.

 37.  Masouredis CM, Katz MH, Greenspan D, et al. Prevalence  



of HIV-associated periodontitis and gingivitis in 

HIV-infected patients attending an AIDS clinic. J Acquir  

Immune Defic Syndr 1992;5:479-83.

 38.  Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing 

ulcerative periodontitis: A marker for immune deterior- 

ation and a predictor for the diagnosis of AIDS. J 

Periodontol 1994;65:393-7.

 39.  American Academy of Periodontology. Periodontal consi-

derations in the HIV-positive patient (position paper). 

Chicago, Ill: The American Academy of Periodontology; 

April 1994.

 40.  Tomar SL, Swango PA, Kleinman DV, Burt BA. Loss 

of periodontal attachment in HIV-seropositive military  

personnel. J Periodontol 1995;66:421-8.

 41.  Redding SW, Montgomery MT. Acyclovir prophylaxis for 

oral herpes simplex infection in patients with bone marrow 

transplants. Oral Surg Oral Med Oral Pathol 1989;67:680-3.

 42.  Hassell TM, Hefti AF. Drug induced gingival over- 

growth: Old problem, new problem. Crit Rev Oral Biol 

Med 1991;2:103-37.

 43.  Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced  

gingival hyperplasia: Phenytoin, cyclosporine, and  

nifedipine. J Am Dent Assoc 1987;114:56-60.

 44.  Miller CS, Damm DD. Incidence of verapamil-induced  

gingival hyperplasia in a dental population. J Periodontol  

1992;63:453-6.

 45.  Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J. 

Prevalence of nifedipine-induced gingival hyperplasia. J 

Periodontol 1995;66:572-8.

 46.  Mealey BL. Periodontal implications: Medically compro-

mised patients. Ann Periodontol 1996;1:303-8.

 47.  Pihlstrom B. Prevention and treatment of dilantin asso- 

ciated gingival enlargement. Compendium Continuing  

Educ Dent 1990;11(suppl 14):S506-S510.

 48.  Hall WB. Dilantin hyperplasia: A preventable lesion? 

Compendium Continuing Educ Dent 1990;11(suppl 14): 

S502-5.

 49.  Jones JE, Weddell JA, McKown CG. Incidence and indi- 



cations for surgical management of phenytoin-induced  

gingival overgrowth in a cerebral palsy population. J Oral 

Maxillofac Surg 1998;46:385-90.

 50.  Hall EE. Prevention and treatment considerations in pa- 

tients with drug-induced gingival enlargement. Curr  

Opin Periodontol 1997;4:59-63.

 51.  Ilgenli T, Atilla G, Baylas H. Effectiveness of periodon-

tal therapy in patients with drug-induced gingival over- 

growth. Long-term results. J Periodontol 1999;70:967-72.

 52.  Morrison EC, Ramfjord SP, Hill RW. Short-term effects  

of initial, nonsurgical periodontal treatment (hygienic 

phase). J Clin Periodontol 1980;7:199-211.

 53.  Garrett JS. Effects of nonsurgical periodontal therapy on 

periodontitis in humans. A review. J Clin Periodontol 1983; 

10:515-23.

 54.  Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical 

periodontal therapy. I. Moderately advanced periodont- 

itis. J Clin Periodontol 1981;8:57-72.

 55.  Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical 

periodontal therapy. II. Severely advanced periodontitis. J 

Clin Periodontol 1984;11:63-76.

 56.  Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical 

periodontal therapy. III. Single versus repeated instru- 

mentation. J Clin Periodontol 1984;11:114-24.

 57.  Hughes TP, Caffesse RG. Gingival changes following scaling, 

root planing and oral hygiene - A biometric evaluation. J 

Periodontol 1978;49:245-52.

 58.  Magnusson I, Lindhe J, Yoneyama T, Liljenberg B. 

Recolonization of subgingival microbiota following scaling 

in deep pockets. J Clin Periodontol 1984;11:193-207.

 59.  Mosques T, Listgarten MA, Phillips RW. Effect of scaling 

and root planing on the composition of the human sub- 

gingival microbial flora. J Periodont Res 1980;15:144-51.

 60.  Pihlstrom BL, McHugh RB, Oliphant TH, Ortiz-Campos 

C. Comparison of surgical and nonsurgical treatment of 

periodontal disease. A review of current studies and ad- 

ditional results after 6-1/2 years. J Clin Periodontol 1983; 

10:524-44.

 61.  Hill RW, Ramfjord SP, Morrison EC, et al. Four types of 

periodontal treatment compared over two years. J Perio- 

dontol 1981;52:655-62.

 62.  Kaldahl WB, Kalkwarf KL, Patil KD, Dyer JK, Bates RE  

Jr. Evaluation of four modalities of periodontal therapy. 

Mean probing depth, probing attachment level, and reces-

sion changes. J Periodontol 1988;59:783-93.

 


372    ENDORSEMENTS 

REFERENCE MANUAL     V 37 

/

 NO 6     15 



/

 16


 63.  Becker W, Becker BE, Ochsenbein C, et al. A longitudinal 

study comparing scaling, osseous surgery, and modified 

Widman procedures. Results after one year. J Periodontol 

1988;59:351-65.

 64.  Ramfjord SP, Caffesse RG, Morrison EC, et al. 4 modalities 

of periodontal treatment compared over 5 years. J Clin 

Periodontol 1987;14:445-52.

 65.  Kaldahl WB, Kalkwarf KL, Kashinath D, Patil D, Molvar 

MP, Dyer JK. Long-term evaluation of periodontal therapy: 

I. Response to 4 therapeutic modalities. J Periodontol 

1996;67:93-102.

 66.  Kalkwarf KL, Kaldahl WB, Patil KD. Evaluation of fur- 

cation region response to periodontal therapy. J Perio- 

dontol 1988;59:794-804.

 67.  Kaldahl WB, Kalkwarf KL, Kashinath D, Patil D, Molvar 

MP, Dyer JK. Long-term evaluation of periodontal  

therapy: II. Incidence of sites breaking down. J Periodontol  

1996;67:103-8.

 68.  Ainslie P, Caffesse R. A biometric evaluation of gingival 

curettage (II). Quintessence Int 1981;6:609-14.

 69.  Echeverra JJ, Caffesse RG. Effects of gingival curettage  

when performed 1 month after root instrumentation. A 

biometric evaluation. J Clin Periodontol 1983;10:277-86.

 70.  Caffesse RG, Sweeney PL, Smith BA. Scaling and root 

planing with and without periodontal flap surgery. J Clin 

Periodontol 1986;13:205-10.

 71.  Rabbani GM, Ash MM, Caffesse RG. The effectiveness of 

subgingival scaling and root planing in calculus removal. J 

Periodontol 1981;52:119-23.

 72.  Fleischer HC, Mellonig JT, Brayer WK, Gray JL, Barnett 

JD. Scaling and root planing efficacy in multirooted  

teeth. J Periodontol 1989;60:402-9.

 73.  Drisko CH. Non-surgical pocket therapy: Pharmaco- 

therapeutics. Ann Periodontol 1996;1:491-566.

 74.  Magnusson I, Low SB, McArthur WP, et al. Treatment 

of subjects with refractory periodontal disease. J Clin 

Periodontol 1994;21:628-37.

 75.  van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological 

and clinical results of metronidazole plus amoxicillin ther- 

apy in Actinobacillus actinomycetemomitans-associated  

periodontitis. J Periodontol 1992;63:52-7.

 76.  Magnusson I, Clark WB, Low SB, Maruniak J, Marks RG, 

Walker CB. Effect of non-surgical periodontal therapy 

combined with adjunctive antibiotics in subjects with 

“refractory” periodontal disease. I. Clinical results. J Clin 

Periodontol 1989;16:647-53.

 77.  Kornman KS, Robertson PB. Clinical and microbio- 

logical evaluation of therapy for juvenile periodontitis. J 

Periodontol 1985;56:443-6.

 78.  Williams R, Jeffcoat M, Howell T, et al. Altering the pro- 

gression of human alveolar bone loss with the non-steroidal 

anti-inflammatory drug flurbiprofen. J Periodontol 

1989;60:485-90.

 

 79.  Williams RC, Jeffcoat MK, Howell TH, et al. Ibuprofen:  



An inhibitor of alveolar bone resorption in beagles. J 

Periodont Res 1988;23:225-9.

 80.  Howell TH, Jeffcoat MK, Goldhaber P, et al. Inhibition of 

alveolar bone loss in beagles with the NSAID naproxen. J 

Periodont Res 1991;26:498-501.

 81.  Crout RJ, Lee HM, Schroeder H, et al. The “cyclic” regimen 

of low-dose doxycycline for adult periodontitis: A pre- 

liminary study. J Periodontol 1996;67:506-14.

 82.  Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treat-

ment with subantimicrobial doses of doxycycline: Effects 

on gingival fluid collagenase activity and attachment loss  

in adult periodontitis. J Clin Periodontol 2001;28:146-56.

 83.  Caton J. Evaluation of Periostat for patient management. 

Compend Continuing Educ Dent 1999;20:451-62.

 84.  Caton J, Ciancio SG, Bleiden TM, et al. Treatment with 

subantimicrobial dose doxycycline improves the efficacy  

of scaling and root planing in patients with adult peri-

odontitis. J Periodontol 2000;71:521-32.

 85.  Walker CB. The acquisition of antibiotic resistance in the 

periodontal microflora. Periodontol 2000 1996;10:79-88.

 86.  Goodson JM, Cugini MA, Kent RL, et al. Multicenter 

evaluation of tetracycline fiber therapy: II. Clinical response. 

J Periodont Res 1991;26:371-9.

 87.  American Academy of Periodontology. The role of con- 

trolled drug delivery for periodontitis (position paper). J 

Periodontol 2000;71:125-40.

 88.  Goodson JM, Tanner A, McArdle S, Dix K, Watanabe SM. 

Multicenter evaluation of tetracycline fiber therapy: III. 

Microbiological response. J Periodont Res 1991;26:440-51.

 89.  Drisko CH, Cobb CM, Killoy WJ, et al. Evaluation of 

periodontal treatments using controlled release tetracycline 

fibers: Clinical response. J Periodontol 1995;66:692-9.

 90.  Michalowicz BS, Pihlstrom BL, Drisko CH, et al. Evaluation 

of periodontal treatments using  controlledrelease tetracy-


Yüklə 172,19 Kb.

Dostları ilə paylaş:
1   2   3




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©azkurs.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin